PA
ZGN icon

PharVision Advisers’s Zegna ZGN Stock Holding History

PharVision Advisers’s Portfolio ZGN Stock Details ZGN Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q2 		– Sell
-12,690
Closed -$132K – 138
2026
Q1 		$132K Buy
+12,690
New +$131K 1.34% 21
2025
Q4 		– Sell
-14,987
Closed -$142K – 1045
2025
Q3 		$142K Buy
+14,987
New +$130K 0.08% 578
2025
Q2 		– Sell
-18,254
Closed -$135K – 452
2025
Q1 		$135K Buy
+18,254
New +$151K 0.19% 233

Other funds holding ZGN

Temasek Holdings
Temasek Holdings Singapore $37.3B AUM 12.6% 1-Year Est. Return
Barrow, Hanley, Mewhinney & Strauss
Barrow, Hanley, Mewhinney & Strauss Dallas, Texas $33B AUM 40.62% 1-Year Est. Return
T. Rowe Price Associates
T. Rowe Price Associates Baltimore, Maryland $999B AUM 46.22% 1-Year Est. Return
BlackRock
BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return
Amundi
Amundi Paris, France $416B AUM 44.19% 1-Year Est. Return
Harris Associates
Harris Associates Chicago, Illinois $75.4B AUM 14.46% 1-Year Est. Return
Point72 Asset Management
Point72 Asset Management Stamford, Connecticut $90.7B AUM 77.13% 1-Year Est. Return
American Century Companies
American Century Companies Kansas City, Missouri $226B AUM 44.75% 1-Year Est. Return
ECSS
Eurizon Capital SGR SpA Milan $37.3B AUM
Artisan Partners
Artisan Partners Milwaukee, Wisconsin $63.1B AUM 35.51% 1-Year Est. Return

PharVision Advisers's ZGN Position: Q2 2026 in Review

PharVision Advisers sold out of Zegna (ZGN) in Q2 2026, closing a stake of 12,690 shares — an estimated $132K sold.

PharVision Advisers first reported a position in ZGN in Q1 2025 and held it in 3 quarters. The position peaked at $142K in Q3 2025. 135 funds tracked by Wall St. Rank hold ZGN as of Q2 2026.

  • PharVision Advisers reported no remaining Zegna position as of Q2 2026 after selling out during the quarter.
  • PharVision Advisers sold 12,690 Zegna shares in Q2 2026, an estimated $132K.
  • PharVision Advisers first reported a position in Zegna in Q1 2025 and held it in 3 quarters.
  • PharVision Advisers's Zegna position peaked at $142K in Q3 2025.
  • 135 funds tracked by Wall St. Rank held Zegna as of Q2 2026.

Based on PharVision Advisers's 13F filing for Q2 2026, filed 11 Aug 2026.